tickrz reports
tickrz rank
A
Humana Inc (HUM)
Healthcare | Health Services
238.99  0.19%
FACTOR RANKINGSFACTOR SCREENER 
tickrz RankA / 64Warren Buffett RankA / 93
Pure Value RankA / 72Dividend RankA / 22
Moat RankD / 388Financial Strength RankN/A
Growth RankB / 220Momentum RankA / 51
HUM vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
HUMSECTORS&P 500
P/E RATIO19.8732.119.28
EV/EBITDA RATIO5.821711.77
P/S RATIO0.673.62.03
P/B RATIO3.295.53.09
QUALITY
RETURN ON EQUITY16.62%15.64%13.82%
RETURN ON CAPITAL995.07%50.61%10.04%
NET MARGIN1.13%8.18%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.55%
PAYOUT RATIO10.53%
3 YR DIVIDEND GROWTH2.73%
FINANCIAL STRENGTH
F SCORE NOT AVAILABLE
DEBT-TO-EQUITY47%
INTEREST COVERAGEN/Ax
CURRENT RATIO1.65
GROWTH
5 YR EPS GROWTH-13.61%
5 YR SPS GROWTH8.1%
5 YR BPS GROWTH7.8%
About tickrz
Key Concepts
Great Investors
tickrz A-Ranked Humana Inc scores well on valuation and momentum
tickrz rank A / 64
Humana Inc receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
value
pure value ranking A / 72Warren Buffett ranking A / 93
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Humana Inc's valuation score is comprised of a P/E ratio of 19.9x, a P/B ratio of 3.3x, a P/S ratio of 0.7x, and an EV/EBITDA ratio of 5.8x. Humana Inc ranks 72 out of the S&P 500 constituents on valuation--a relatively strong score.Humana Inc ranks 93 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Humana Inc warrants further investigation.

quality
moat D / 388financial strength N/A
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.A debt/equity ratio of 47% and a Moat Rank of 388 translate to a not available Financial Strength score.


momentum A / 51
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 41.22% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 51. Humana Inc's strong 12 month stock performance will appeal to momentum investors.

yield A / 22
value + yield
Shares currently yield 0.55%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Humana Inc ranks 22 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate Humana Inc.

growth B / 220
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. -13.6% 5 year annualized EPS growth, 8.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 7.8% combine to produce this average score.

Humana Inc (HUM)
Healthcare | Health Services
238.99  0.19%


tickrz rank
A
VALUATION RATIOS
P/E Ratio19.87x
P/B Ratio3.29x
P/S Ratio0.67x
EV/EBITDA Ratio5.82x
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.55%
PAYOUT RATIO10.53%
3 YR DIVIDEND GROWTH2.73%
FINANCIAL STRENGTH
F SCORE NOT AVAILABLE
DEBT-TO-EQUITY47%
INTEREST COVERAGEN/Ax
CURRENT RATIO1.65
MOAT
ROE16.62%
ROIC995.07%
Net Margin1.13%
GROWTH
5 YR EPS GROWTH-13.61%
5 YR SPS GROWTH8.1%
5 YR BPS GROWTH7.8%

TICKRZ RANK
Humana Inc receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Humana Inc's valuation score is comprised of a P/E ratio of 19.9x, a P/B ratio of 3.3x, a P/S ratio of 0.7x, and an EV/EBITDA ratio of 5.8x. Humana Inc ranks 72 out of the S&P 500 constituents on valuation--a relatively strong score.

WARREN BUFFETT RANKING
Humana Inc ranks 93 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Humana Inc warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.

FINANCIAL STRENGTH
A debt/equity ratio of 47% and a Moat Rank of 388 translate to a not available Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 41.22% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 51. Humana Inc's strong 12 month stock performance will appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.55%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Humana Inc ranks 22 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate Humana Inc.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. -13.6% 5 year annualized EPS growth, 8.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 7.8% combine to produce this average score.